These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8108139)

  • 21. Microarray assessment of fibronectin, collagen and integrin expression and the role of fibronectin-collagen coating in the growth of normal, SV40 T-antigen-immortalised and malignant human oral keratinocytes.
    Sarang Z; Haig Y; Hansson A; Vondracek M; Wärngård L; Grafström R
    Altern Lab Anim; 2003 Dec; 31(6):575-85. PubMed ID: 15560747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and functional analysis of the expression of vascular adhesion molecules in human papillomavirus-related disease of the cervix.
    Coleman N; Stanley MA
    Cancer; 1994 Aug; 74(3):884-92. PubMed ID: 7518736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two strains of human keratinocytes transfected with HPV16 DNA: comparison with the normal parental cells.
    Pei XF; Gorman PA; Watt FM
    Carcinogenesis; 1991 Feb; 12(2):277-84. PubMed ID: 1847319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide.
    Kadish AS; Timmins P; Wang Y; Ho GY; Burk RD; Ketz J; He W; Romney SL; Johnson A; Angeletti R; Abadi M;
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):483-8. PubMed ID: 12010863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation ability and oncogenic potential of HPV-33- and HPV-33 + ras-transfected keratinocytes.
    Gilles C; Piette J; Peter W; Fusenig NE; Foidart JM
    Int J Cancer; 1994 Sep; 58(6):847-54. PubMed ID: 7927877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
    de Gruijl TD; Bontkes HJ; Stukart MJ; Walboomers JM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2183-91. PubMed ID: 8811018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions.
    Kojima S; Kawana K; Fujii T; Yokoyama T; Miura S; Tomio K; Tomio A; Yamashita A; Adachi K; Sato H; Nagamatsu T; Schust DJ; Kozuma S; Taketani Y
    Am J Reprod Immunol; 2011 Nov; 66(5):435-43. PubMed ID: 21749545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens.
    Elfgren K; Bistoletti P; Dillner L; Walboomers JM; Meijer CJ; Dillner J
    Am J Obstet Gynecol; 1996 Mar; 174(3):937-42. PubMed ID: 8633673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of integrin expression and terminal differentiation capacity in cell lines derived from oral squamous cell carcinomas.
    Sugiyama M; Speight PM; Prime SS; Watt FM
    Carcinogenesis; 1993 Oct; 14(10):2171-6. PubMed ID: 7693359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody levels against galactosyl (alpha1 --> 3) galactose epitopes in cervical mucus from patients with human papillomavirus infection.
    Hernàndez DE; Cohen A; Fisher D; Correnti M; Harner R
    Gynecol Oncol; 2002 Mar; 84(3):374-7. PubMed ID: 11855872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population.
    Zazove P; Reed BD; Gregoire L; Gorenflo DW; Lancaster WD; Ruffin MT; Hruszczyk J
    Arch Fam Med; 1993 Dec; 2(12):1250-8. PubMed ID: 8130906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of HPV infection in CIN and invasive cancers by in situ hybridization method--comparison with histopathology].
    Ishi K; Saito A; Kina K; Kawashima T; Utsuno H; Nakamura H; Igari J
    Rinsho Byori; 1993 Oct; 41(10):1167-72. PubMed ID: 8254963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia.
    Kadish AS; Ho GY; Burk RD; Wang Y; Romney SL; Ledwidge R; Angeletti RH
    J Natl Cancer Inst; 1997 Sep; 89(17):1285-93. PubMed ID: 9293919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The E2 region of HPV 16 in relation to different types of cervical lesions.
    Krajinovic M; Lazic J; Stanimirovic B; Diklic V; Savic A
    J Med Virol; 1993 Sep; 41(1):1-5. PubMed ID: 8228930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women.
    Levi JE; Fernandes S; Tateno AF; Motta E; Lima LP; Eluf-Neto J; Pannuti CS
    Gynecol Oncol; 2004 Jan; 92(1):225-31. PubMed ID: 14751163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA-Seq Analysis of Differentiated Keratinocytes Reveals a Massive Response to Late Events during Human Papillomavirus 16 Infection, Including Loss of Epithelial Barrier Function.
    Klymenko T; Gu Q; Herbert I; Stevenson A; Iliev V; Watkins G; Pollock C; Bhatia R; Cuschieri K; Herzyk P; Gatherer D; Graham SV
    J Virol; 2017 Dec; 91(24):. PubMed ID: 29021401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of herpes virus simplex and cytomegalovirus as cofactors of papillomavirus in dysplastic and cancerous lesions of the uterine cervix].
    Baldauf JJ; Dreyfus M; Monlun E; Ritter J; Obert G
    Chirurgie; 1992; 118(10):652-8. PubMed ID: 1345699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA.
    Wang Z; Hansson BG; Forslund O; Dillner L; Sapp M; Schiller JT; Bjerre B; Dillner J
    J Clin Microbiol; 1996 Dec; 34(12):3056-62. PubMed ID: 8940448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.